Indigenous Covaxin phase-3 trial results in November 2021, says NICED
Naven Kumar Wednesday 2nd of December 2020 08:13 PM
(0) (0)
Covaxin, the first indigenously-developed anti-coronavirus vaccine, is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Read more: HINDUSTANTIMES.COM
Leave Your Response